Sijumon Kunjachan is an Instructor/junior faculty in Radiation Oncology at Harvard Medical School and conducts research at Dana-Farber Cancer Institute and Brigham and Women’s Hospital. Following a 6 yr-Bachelor plus Master’s degree in Pharmaceutical Sciences (2000-2007), Sijumon carried out research at Central Drug Research Institute and Indian Institute of Technology Kanpur (2007-2010). In 2013, Sijumon was awarded a PhD in Experimental Medicine (2010-2013) from RWTH-Aachen University, Germany.
Dr. Kunjachan's research aims to identify and tackle various pathophysiological barriers that prevent effective delivery of drugs or biologics, and to devise novel nanotechnology platforms to improve therapy in cancer or infectious disease. Over the years, Dr. Kunjachan acquired substantial knowledge and experience in the field of nanomedicine, noninvasive imaging, radiation therapy and drug delivery. His research findings are published in high-impact journals, including Nano Letters, Chemical Reviews, ACS Nano, Theranostics, Advanced Drug Del Rev, JCR etc. His research is widely cited with ~1000+ citations since 2012. Dr. Kunjachan sits on the editorial board of four international journals and serve as an assigned editor for Clinical & Experimental Oncology. He reviews articles for 40+ scientific journals, including Clinical Cancer Research, Cancer Research, Nanoscale, Nano Research, Biomaterials, Theranostics, Medical Physics, Nature Scientific Reports, and Journal of Controlled Release. He reviews grant for several national and international funding agencies, including Cost-Action (EU) and National Research, Development and Innovation Office (Hungary) and evaluates abstracts for scientific conferences (incl. WMIC, ICONAN, etc.). Twice-featured as a vodcast speaker at the Radiation Research meeting, Dr. Kunjachan delivered invited talks at ASTRO, AAPM, National Nanomedicine Seminar and World Molecular Imaging conferences. Sijumon is a recipient of several awards, including, Scholar-in-Training Award, Elsevier Reviewer Recognition Award and the World Molecular Imaging-Young Investigator Award (finalist).